The Just Price of Cancer Drugs
Not all new drugs for cancer come with vast improvements, yet many share one trait in common: a high price. Oncologists need to be part of the solution.
Originally published on 10/01/2013 in The Journal of Clinical Oncology
Dr. David Pfister of Memorial Sloan Kettering Cancer Center summarizes the work that Dr. Bach and colleagues regarding the high cost of cancer treatments and alternative pricing methods.
Read the full article here.